Commission Implementing Regulation (EU) 2026/398 of 18 February 2026 amending Implementing Regulation (EU) No 686/2012 as regards the allocation to Member States, for the purposes of the renewal procedure, of the evaluation of metconazole and quinolin-8-ol

• CELEX: Implementing Regulation (EU) 2026/398
• Articles: 2

Article 1

Part E of the Annex to Implementing Regulation (EU) No 686/2012 is amended as follows:

(1)

the following entry is inserted after the entry for ‘Metalaxyl-M’:

Active substance

Rapporteur Member State

Co-rapporteur Member State

‘Metconazole

SE

BE’

(2)

the following entry is inserted after the entry for ‘Pyriproxyfen’:

Active substance

Rapporteur Member State

Co-rapporteur Member State

‘Quinolin-8-ol

NL

BE’

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .